Downregulation of CD73/A2AR-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis.
Milorad DragicMilica ZeljkovićIvana StevanovićMarija AdžićAndjela StekićKatarina MihajlovicIvana GrkovićNela IlićTihomir V IlićNadežda NedeljkovićMilica NinkovićPublished in: Brain sciences (2021)
Multiple sclerosis (MS) is a chronic neurodegenerative disease caused by autoimmune-mediated inflammation in the central nervous system. Purinergic signaling is critically involved in MS-associated neuroinflammation and its most widely applied animal model-experimental autoimmune encephalomyelitis (EAE). A promising but poorly understood approach in the treatment of MS is repetitive transcranial magnetic stimulation. In the present study, we aimed to investigate the effect of continuous theta-burst stimulation (CTBS), applied over frontal cranial bone, on the adenosine-mediated signaling system in EAE, particularly on CD73/A2AR/A1R in the context of neuroinflammatory activation of glial cells. EAE was induced in two-month-old female DA rats and in the disease peak treated with CTBS protocol for ten consecutive days. Lumbosacral spinal cord was analyzed immunohistochemically for adenosine-mediated signaling components and pro- and anti-inflammatory factors. We found downregulated IL-1β and NF- κB-ir and upregulated IL-10 pointing towards a reduction in the neuroinflammatory process in EAE animals after CTBS treatment. Furthermore, CTBS attenuated EAE-induced glial eN/CD73 expression and activity, while inducing a shift in A2AR expression from glia to neurons, contrary to EAE, where tight coupling of eN/CD73 and A2AR on glial cells is observed. Finally, increased glial A1R expression following CTBS supports anti-inflammatory adenosine actions and potentially contributes to the overall neuroprotective effect observed in EAE animals after CTBS treatment.
Keyphrases
- transcranial magnetic stimulation
- high frequency
- multiple sclerosis
- spinal cord
- anti inflammatory
- poor prognosis
- neuropathic pain
- mass spectrometry
- induced apoptosis
- oxidative stress
- signaling pathway
- drug induced
- spinal cord injury
- traumatic brain injury
- protein kinase
- randomized controlled trial
- high glucose
- immune response
- bone mineral density
- combination therapy
- liver failure
- long non coding rna
- inflammatory response
- replacement therapy
- hepatitis b virus
- risk assessment
- soft tissue
- functional connectivity
- lipopolysaccharide induced
- brain injury
- nuclear factor